Peter Duggan

Dr. Peter Duggan

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2004 in Inorganic Chemistry
Verified
Journal Article
Closed access
JMJoseph M. Mahoney
Joseph M. Mahoney
GNGayathri U. Nawaratna
Gayathri U. Nawaratna
ABAlicia M. Beatty
Alicia M. Beatty
PDPeter Duggan
Peter Duggan
BSBradley D. Smith
Bradley D. Smith

1 July 2014 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
QCQuentin I. Churches
Quentin I. Churches
JCJoanne Caine
Joanne Caine
KCKate Cavanagh
Kate Cavanagh
VEVidana Chandana Epa
Vidana Chandana Epa
LWLynne Waddington
Lynne Waddington
PDPeter Duggan
Peter Duggan

9 May 2002 in Journal of the Chemical Society, Perkin Transactions 1
Verified
Journal Article
Closed access
PDF file
PDPeter Duggan
Peter Duggan
ETEdward M. Tyndall
Edward M. Tyndall
Covering: 1978–2000. Previous review: R. J. Ferrier, Adv. Carbohydr. Chem. Biochem., 1978, 35, 31–80.

18 March 2021 in Australian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
PDPeter Duggan
Peter Duggan
The science of cannabis and cannabinoids encompasses a wide variety of scientific disciplines and can appear daunting to newcomers to the field. The encroachment of folklore and ‘cannabis culture’ into scientific discussions can cloud the situation further. This Primer Review is designed to give a succinct overview of the chemistry of cannabis and cannabinoids. It is hoped that it will provide a useful resource for chemistry undergraduates, postgraduates and their instructors, and experienced chemists who require a comprehensive and up to date summary of the field. The Review begins with a brief overview of the history and botany of cannabis, then goes on to detail important aspects of the chemistry of phytocannabinoids, endocannabinoids and synthetic cannabinomimetics. Other natural constituents of the cannabis plant are then described including terpenes and terpenoids, polyphenolics, alkaloids, waxes and triglycerides, and important toxic contaminants. A discussion of key aspects of the pharmacology associated with cannabinoids and the endocannabinoid system then follows, with a focus on the cannabinoid receptors, CB1 and CB2. The medicinal chemistry of cannabis and cannabinoids is covered, highlighting the range of diseases targeted with cannabis and phytocannabinoids, as well as key aspects of phytocannabinoid metabolism, distribution, and delivery. The modulation of endocannabinoid levels through the inhibition of key endocannabinoid-degrading enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) is then discussed. The Review concludes with an assessment of the much touted ‘entourage effect’. References to primary literature and more specialised reviews are provided throughout.

1 December 2001 in Journal of Membrane Science
Verified
Journal Article
Closed access
KWKimberly M. White
Kimberly M. White
BSBradley D. Smith
Bradley D. Smith
PDPeter Duggan
Peter Duggan
SSSarah L. Sheahan
Sarah L. Sheahan
ETEdward M. Tyndall
Edward M. Tyndall

1 March 1999 in Tetrahedron
Verified
Journal Article
Open access
SGStephen J Gardiner
Stephen J Gardiner
BSBradley D Smith
Bradley D Smith
PDPeter Duggan
Peter Duggan
MKMicheal J Karpa
Micheal J Karpa
GGGregory J Griffin
Gregory J Griffin